Your session is about to expire
← Back to Search
Web-Based Cognitive Behavioral Therapy for Caregiver Insomnia (NiteCAPP Trial)
NiteCAPP Trial Summary
This trial will examine whether web-based CBT-I is efficacious in reducing insomnia and improving mood in caregivers of persons with dementia.
NiteCAPP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NiteCAPP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't taken sleep meds recently or have been stable on them for over 6 weeks.I have been diagnosed with insomnia.I have had trouble sleeping for over 6 months.I am on medication that affects my sleep.I have a sleep disorder that is not insomnia, such as severe sleep apnea.I have been diagnosed with bipolar disorder or a seizure disorder.I am unable to give consent by myself.I am receiving treatments like therapy for sleep or mood issues not related to this trial.I am 18 years old or older.I have trouble falling or staying asleep, or I wake up too early.My insomnia affects my mood, thinking, social life, or work during the day.
- Group 1: NiteCAPP: Online Cognitive Behavioral Therapy for Insomnia
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical experiment have open vacancies for participants?
"According to clinicaltrials.gov, this scientific investigation is actively recruiting participants since its inception on January 1st 2022 and most recently modified April 26th 2021."
What is the desired outcome of this investigation?
"This 6-week trial aims to assess Objective Daily Sleep Actiwatch-2 - Sleep Efficiency as its primary objective. As secondary objectives, the study looks at three other metrics: Beck Depression Inventory Second Edition (BDI-II), Perceived Stress Scale (PSS) and Kingston Caregiver Stress Scale. The BDI II measures depressive symptoms on a scale of 0 to 63; the PSS gauges perceived stress from 0 to 40, while the KCSS evaluates caregiver stress from 10 to 50 with higher scores correlating with greater levels of both depression and stress."
How many test subjects are currently enrolled in this experiment?
"Indeed, the clinicaltrials.gov website affirms that this medical trial is currently recruiting participants; it was initially published on January 1st 2022 and edited most recently April 26th 2021. The investigation requires 60 subjects to be enrolled at a single site."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger